Evaluation of 3 Different Doses of IV Busulfan

NCT01985061 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

177

Enrollment

OTHER

Sponsor class

Conditions

Myelodysplastic Syndrome
Acute Myeloid Leukemia

Interventions

DRUG: BX2
DRUG: BX3
DRUG: BX4-Suspended

Sponsor

Institut Paoli-Calmettes